Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology (Q47183148)

11 January 2018

title

Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology (English)

1 reference

11 January 2018

author name string

Mark Walzer

1

1 reference

11 January 2018

Stanley Lorens

2

1 reference

11 January 2018

Matthew Hejna

3

1 reference

11 January 2018

Jawed Fareed

4

1 reference

11 January 2018

Israel Hanin

5

1 reference

11 January 2018

Umberto Cornelli

6

1 reference

11 January 2018

John M Lee

7

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 June 2002

1 reference

11 January 2018

European Journal of Pharmacology

published in

1 reference

11 January 2018

volume

445

1 reference

11 January 2018

page(s)

211-220

1 reference

11 January 2018

issue

3

1 reference

11 January 2018

Molecular profiling and weight determination of heparins and depolymerized heparins.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

An update on heparins at the beginning of the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Alzheimer's disease and heparan sulfate proteoglycan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Pharmacologic profile of certoparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

A serine-->proline change in the Alzheimer's disease-associated epitope Tau 2 results in altered secondary structure, but phosphorylation overcomes the conformational gap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

A sulfated proteoglycan aggregation factor mediates amyloid-beta peptide fibril formation and neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Heparin modulation of the neurotropic effects of acidic and basic fibroblast growth factors and nerve growth factor on PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Phosphorylation determines two distinct species of Tau in the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Glycosaminoglycans and sulphated polyanions attenuate the neurotoxic effects of beta-amyloid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Sulfated glycosaminoglycans in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Tau 2: a probe for a Ser conformation in the amino terminus of tau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901759-4

10.1016/S0014-2999(02)01759-4

7 January 2021

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

12079686

1 reference

11 January 2018